(Q37810239)

23 August 2017

title

Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges (English)

1 reference

23 August 2017

Sarah M R Wille

1

1 reference

23 August 2017

Maria Del Mar Ramírez-Fernandez

series ordinal

2

1 reference

23 August 2017

Nele Samyn

series ordinal

3

1 reference

23 August 2017

Gert De Boeck

series ordinal

4

1 reference

23 August 2017

publication date

1 April 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

2

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

791-806

1 reference

A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions

23 August 2017

cites work

1 reference

The prevalence of drugs and alcohol found in road traffic fatalities: a comparative study of victims

21 January 2018

1 reference

Use of drugs of abuse in less than 30-year-old drivers killed in a road crash in France: a spectacular increase for cannabis, cocaine and amphetamines.

21 January 2018

1 reference

Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood

21 January 2018

1 reference

Injury risk associated with cannabis and cocaine use.

21 January 2018

1 reference

21 January 2018

1 reference

The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes.

21 January 2018

1 reference

21 January 2018

1 reference

Practical aspects of roadside tests for administrative traffic offences in Germany

21 January 2018

1 reference

Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine

21 January 2018

1 reference

Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.

21 January 2018

1 reference

Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids

21 January 2018

1 reference

Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing

21 January 2018

1 reference

Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint

21 January 2018

1 reference

Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens

21 January 2018

1 reference

Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid

21 January 2018

1 reference

Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis

21 January 2018

1 reference

Review: Pharmacokinetics of illicit drugs in oral fluid

21 January 2018

1 reference

Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

21 January 2018

1 reference

The effect of cannabis compared with alcohol on driving

21 January 2018

1 reference

Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms

21 January 2018

1 reference

The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.

21 January 2018

1 reference

Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.

21 January 2018

1 reference

Developing limits for driving under cannabis

21 January 2018

1 reference

Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs

21 January 2018

1 reference

Screening for drugs of abuse in oral fluid--correlation of analysis results with serum in forensic cases

21 January 2018

1 reference

Excretion of Delta9-tetrahydrocannabinol in sweat

21 January 2018

1 reference

Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.

21 January 2018

1 reference

Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.

21 January 2018

1 reference

Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.

21 January 2018

1 reference

Evaluation of the Cozart DDSV test for cannabis in oral fluid

21 January 2018

1 reference

Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.

21 January 2018

1 reference

Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS.

21 January 2018

1 reference

Detection of cannabis use in drivers with the drugwipe device and by GC-MS after Intercept device collection

21 January 2018

1 reference

Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays

21 January 2018

1 reference

Drugs in oral fluid in randomly selected drivers.

21 January 2018

1 reference

Bioanalytical procedures for determination of drugs of abuse in oral fluid

21 January 2018

1 reference

Oral fluid testing for drugs of abuse

21 January 2018

1 reference

Mass spectrometric approaches in impaired driving toxicology.

21 January 2018

1 reference

Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

Fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry for forensic analysis of cannabinoids in whole blood

21 January 2018

1 reference

The analysis of delta9-tetrahydrocannabinol and metabolite in whole blood and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using disposable pipette extraction with confirmation and quantification by gas chromatography-mass spectrome

21 January 2018

1 reference

A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood.

21 January 2018

1 reference

Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS.

21 January 2018

1 reference

Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-

21 January 2018

1 reference

Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract

21 January 2018

1 reference

Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.

21 January 2018

1 reference

Quantitative analysis of delta9-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

Liquid chromatography/tandem mass spectrometry for the qualitative and quantitative analysis of illicit drugs and medicines in preserved oral fluid

21 January 2018

1 reference

Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS.

21 January 2018

1 reference

Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid.

21 January 2018

1 reference

Analysis of Delta9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry.

21 January 2018

1 reference

Rapid determination of Delta9-Tetrahydrocannabinol in saliva by polymer monolith microextraction combined with gas chromatography-mass spectrometry

21 January 2018

1 reference

Drug testing in oral fluid-evaluation of sample collection devices

21 January 2018

1 reference

Introduction and review of collection techniques and applications of drug testing of oral fluid

21 January 2018

1 reference

Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device.

21 January 2018

1 reference

Development and validation of the Cozart DDS oral fluid collection device.

21 January 2018

1 reference

Guidelines for research on drugged driving

21 January 2018

1 reference

Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations

21 January 2018

1 reference

Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol

21 January 2018

1 reference

Passive cannabis smoke exposure and oral fluid testing

21 January 2018

1 reference

Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle

21 January 2018

1 reference

Stability of 9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC in Blood and Plasma

21 January 2018

1 reference

Tetrahydrocannabinol stability in whole blood: plastic versus glass containers

21 January 2018

1 reference

Importance of vacutainer selection in forensic toxicological analysis of drugs of abuse

21 January 2018

1 reference

Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes.

21 January 2018

1 reference

Proficiency testing (external quality assessment) of drug detection in oral fluid

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/BIO.10.29

1 reference

23 August 2017

1 reference